BRAINLIFE.ORG





Topics


Glioblastoma | Diagnosis | Biomarkers






Home > Publications > Topics > Glioblastoma > Diagnosis > Biomarkers






EGFR


IDH






Katole VR, Kaple M.
Unraveling the Landscape of Pediatric Glioblastoma Biomarkers: A Comprehensive Review of Enhancing Diagnostics and Therapeutic Insights.
Cureus. 2024 Mar 30;16(3):e57272. doi: 10.7759/cureus.57272. PMID: 38686271. Review. ˍ




*Gonçalves JM, Carvalho B, Tuna R, Polónia P, Linhares P.
Sequential Evaluation of Hematology Markers as a Prognostic Factor in Glioblastoma Patients.
Biomedicines. 2024 May 12;12(5):1067. doi: 10.3390/biomedicines12051067. PMID: 38791033. Observational study. ˍ




John D, Alshalalfa M, Almeida T, Murray A, Marques J, Azzam G, Mellon EA, Benjamin CG, Komotar RJ, Ivan M, Mahal B, Rich BJ.
Racial Disparities in Glioblastoma Genomic Alterations: A Comprehensive Analysis of a Multi-institution Cohort of 2,390 patients.
World Neurosurg. 2024 Jun 4:S1878-8750(24)00945-8. doi: 10.1016/j.wneu.2024.05.183. PMID: 38843966. Observational study˰ ˍ




Tataranu LG, Turliuc S, Rizea RE, Dricu A, Alexandru O, Staicu GA, Kamel A.
A Synopsis of Biomarkers in Glioblastoma: Past and Present.
Curr Issues Mol Biol. 2024 Jul 3;46(7):6903-6939. doi: 10.3390/cimb46070412. PMID: 39057054. Review. ˍ